Scan beyond Axon Enterprise and identify other public safety and AI infrastructure plays by focusing on our hand picked list of 92 AI infrastructure stocks.
For Axon Enterprise, the core investment belief is that public safety agencies continue to standardise on its full stack of hardware, software, and AI, and then renew on multi year terms. The new corrections wins and the Lakeland contract both support that recurring contract narrative and help offset recent share price weakness. However, they do not change the fact that the key near term swing factor is execution on Software and Services growth and AI Era plans.
The main operational risk remains tied to pressure on connected devices margins, rising costs for newer offerings such as counter drone systems, and reliance on government budgets. If those costs remain elevated or if funding cycles soften, it could limit how much bookings translate into higher profitability, even with solid contract activity in corrections and municipal deals.
The Lakeland, Florida ten year, roughly US$22 million agreement is the clearest companion to these corrections announcements. It illustrates how Axon Enterprise is securing long duration, bundled contracts that include cameras, TASER devices, in car video, AI driven software, and Drone as First Responder. When paired with the new state prison deployments, this structure can provide more predictable cash flow visibility.
That kind of contract structure is relevant for catalysts that investors are monitoring, including recurring revenue growth, AI powered platform adoption, and the ability to support the US$1.6b annual recurring revenue base and US$15.1b of future contracted bookings. It also exists alongside ongoing concerns about valuation, margin pressure, and the US$1b convertible notes, which keep execution risk prominent even with solid operational traction.
Axon Enterprise’s current analyst framework leans heavily on aggressive compounding for both sales and profit. Consensus expects revenue to expand by 28.8% per year over the next 3 years, with profit margins moving from 6.2% today to 6.5% in that same window, while earnings are projected to climb from US$199.3 million today to US$445.3 million by 2029 on earnings per share of US$5.59.
Axon Enterprise's narrative projects US$6.9 billion revenue and US$445.3 million earnings by 2029. This requires 28.8% yearly revenue growth and about US$246 million earnings increase from US$199.3 million today.
That profit step up is not just about higher volume. The story assumes Axon Enterprise shifts a larger share of customer spend into premium bundles, AI heavy subscriptions, and long duration contracts similar to the Lakeland deal and the new corrections deployments. It also bakes in share count creeping higher at roughly 2.95% per year, which matters because any future earnings pool has to stretch across more stock to support current valuation expectations.
The P/E side of the model indicates how much conviction is built into the current setup. To align with the consensus price target of US$704.11, analysts are effectively assuming Axon Enterprise trades on a 176.6x P/E multiple on those projected 2029 earnings. That is above the 35.5x P/E used for the broader US Aerospace & Defense industry and only slightly below the 184.3x multiple implied today. For an investor, the key question is whether that premium multiple still feels reasonable once you factor in execution risk in AI products, connected devices margins, and the US$1b of 0% convertible notes.
Uncover why Axon Enterprise's fair value indicates a 66% potential upside to its current price that may be short-lived.
Some of the most optimistic analysts focus on Axon Enterprise’s AI Era Plan as the real swing factor. Before these corrections and Lakeland wins, that bullish group was already pencilling in about US$7.9b revenue and US$949.1m earnings by 2029. You can see how far opinions stretch, so it is best to treat this news as a prompt to compare several viewpoints, not a final verdict.
Explore 5 other Axon Enterprise fair value estimates, including one that suggests potential upside of as much as 66% from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If you want to pressure test your Axon Enterprise thesis against other opportunities, a quick pass through the Simply Wall St Screener can surface stocks with very different risk and reward profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com